Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-fv566 Total loading time: 0 Render date: 2024-07-20T14:17:24.581Z Has data issue: false hasContentIssue false

Chapter 6 - Fibrous and myofibroblastic tumors and reactive lesions

Published online by Cambridge University Press:  05 July 2016

Ophelia E. Dadzie
Affiliation:
Hillingdon Hospitals NHS Foundation Trust
Meera Mahalingam
Affiliation:
VA Consolidated Laboratories, New England
Get access
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Primary Sources

Lin, X.Y., Wang, L., Zhang, Y., et al. (2008). Variable Ki67 proliferative index in 65 cases of nodular fasciitis, compared with fibrosarcoma and fibromatosis. Diagn Pathol, 8, 50.Google Scholar
Nishio, J. (2013). Updates on the cytogenetics and molecular cytogenetics of benign and intermediate soft tissue tumors (Review). Oncol Lett, 5, 1218.CrossRefGoogle Scholar
Lazar, A., Evans, H.L., and Oliveira, A.M. (2013). Nodular fasciitis. In WHO Classification of Tumors of Soft Tissue and Bone. 4th ed. Lyon: IARC, 46–7.Google Scholar
de Feraudy, S. and Fletcher, C.D. (2010). Intradermal nodular fasciitis: a rare lesion analyzed in a series of 24 cases. Am J Surg Pathol, 34, 1377–81.Google Scholar

Secondary Sources

Satter, E.K. and Dela Rosa, K.M. (2013). Intradermal proliferative fasciitis on the finger. Am J Dermatopathol, 15, 13.Google Scholar
Rosa, G. and Billings, S.D. (2014). A report of three cases of pediatric proliferative fasciitis. J Cutan Pathol, 41, 720–3.CrossRefGoogle ScholarPubMed
Magro, G., Michal, M., Alaggio, R., et al. (2009). Intradermal proliferative fasciitis in childhood: a potential diagnostic pitfall. J Cutan Pathol, 38, 5962.Google Scholar
Rosenberg, A.E. (2008). Pseudosarcomas of soft tissue. Arch Pathol Lab Med, 132, 579–8.Google Scholar
Liegl-Atzwanger, B. (2013). Ischaemic fasciitis. In WHO Classification of Tumors of Soft Tissue and Bone. 4th ed. Lyon: IARC, 52.Google Scholar
Liegl, D. and Fletcher, C. (2008). Ischemic fasciitis: Analysis of 44 cases indicating an inconsistent association with immobility or debilitation. Am J Surg Pathol, 32, 1546–52.Google Scholar
Sayeed, S., Tyrell, R., and Glickman, L. (2014). Management of recurrent ischemic fasciitis, a rare soft tissue pseudosarcoma. Arch Plast Surg, 41, 8990.Google Scholar
Rosenberg, A.E. (2008). Pseudosarcomas of soft tissue. Arch Pathol Lab Med, 132, 579–86.Google Scholar
McComb, E.N., Feely, M.G., Neff, J.R., et al. (2001). Cytogenetic instability, predominantly involving chromosome 1, is characteristic of elastofibroma. Cancer Genet Cytogenet, 126, 6872.CrossRefGoogle ScholarPubMed
Yamazaki, K. (2007). An ultrastructural and immunohistochemical study of elastofibroma: CD34, MEF-2, prominin 2 (CD133), and factor XIIIa-positive proliferating fibroblastic stromal cells connected by Cx43-type gap junctions. Ultrastruct Pathol, 31, 209–19.Google Scholar
Karakurt, O., Kaplan, T., and Gunal, N. (2014). Elastofibroma dorsi management and outcomes: review of 16 cases. Interact CardioVasc Thorac Surg, 18, 197201.Google Scholar
Rosenberg, A.E. and Oliveira, A.M. (2013). Myositis ossificans and fibro-osseous pseudotumor of digits. WHO Classification of Tumors of Soft Tissue and Bone. 4th ed. Lyon: IARC, 50–1.Google ScholarPubMed
Chaudhry, I., Kazakov, D., Michal, M., et al. (2010). Fibro-osseous pseudotumor of the digit: a clinicopathologic study of 17 cases. J Cutan Pathol, 37, 323–9.Google Scholar
Javdan, M. and Tahririan, M. (2012). Fibro-osseous pseudotumor of the digit. Adv Biomed Res, 1, 31.Google Scholar
De Silva, M.V. and Reid, R. (2003). Myositis ossificans and fibroosseous pseudotumor of digits: a clinicopathologic review of 64 cases with emphasis on diagnostic pitfalls. Int J Surg Pathol, 11, 187–95.Google Scholar
Saab, S.T., McClain, C.M., and Coffin, C.M. (2014). Fibrous hamartoma of infancy: a clinicopathologic analysis of 60 cases. Am J Surg Pathol, 38, 394401.Google Scholar
Tassano, E., Nozza, P., Tavella, E., et al. (2010). Cytogenetic characterization of a fibrous hamartoma of infancy with complex translocations. Cancer Genet Cytogenet, 201, 66–9.Google Scholar
Takahashi, E., Yokozeki, H., and Satoh, T. (2013). Atrophic fibrous hamartoma of infancy with epidermal and adnexal changes. J Dermatol, 40, 212–14.Google Scholar
Linos, K., Carter, J.M., Gardner, J.M., et al. (2014). Myofibromas with atypical features: expanding the morphologic spectrum of a benign entity. Am J Surg Pathol, 38, 1649–54.Google Scholar
Fletcher, C., Bridge, J., Hogendoorn, P., et al. (2013). WHO Classification of Tumors of Soft Tissue and Bone. 4th ed. Lyon: IARC; 46–7 and 118–20.Google Scholar
Oudijk, L., den Bakker, M.A., Hop, W.C., et al. (2012). Solitary, multifocal and generalized myofibromas: clinicopathologic and immunohistochemical features of 114 cases. Histopathology, 60, E111.Google Scholar
Kamino, H., Reddy, V., and Pui, J. (2012). Fibrous and fibrohistiocytic proliferations of skin and tendons. In Dermatology . 3rd ed. Philadelphia: Elsevier, 1961–77.Google Scholar
Tardío, J.C., Azorín, D., Hernandez-Nunez, A., et al. (2011). Dermatomyofibromas presenting in pediatric patients: clinicopathologic characteristics and differential diagnosis. J Cutan Pathol, 38, 967–72.Google Scholar
Mentzel, T. and Kutzner, H. (2009). Dermatomyofibroma: clinicopathologic and immunohistochemical analysis of 56 cases and reappraisal of a rare and distinct cutaneous neoplasm. Am J Dermatopathol, 31, 44–9.Google Scholar
Kamino, H., Reddy, V.B., Gero, M., et al. (1992). Dermatomyofibroma. A benign cutaneous, plaque-like proliferation of fibroblasts and myofibroblasts in young adults. J Cutan Pathol, 19, 8593.Google Scholar
Brenn, T. (2014). Pleomorphic dermal neoplasms: a review. Adv Anat Pathol, 21, 108–30.Google Scholar
Yadav, Y.K., Kushwaha, R., Sharma, U., et al. (2013). Cytomorphology of pleomorphic fibroma of skin: a diagnostic enigma. J Cytol, 30, 71–3.Google Scholar
Nakamura, Y., Nakamura, A., and Muto, M. (2013). A case of pleomorphic fibroma of the skin presenting as an intradermal nodule. Am J Dermatopathol, 37, 175–6.Google Scholar
Kamino, H., Lee, J.Y., and Berke, A. (1989). Pleomorphic fibroma of the skin: a benign neoplasm with cytologic atypia. A clinicopathologic study of eight cases. Am J Surg Pathol, 13, 107–13.Google Scholar
High, W.A., Stewart, D., Essary, L.R., et al. (2004). Sclerotic fibroma-like change in various neoplastic and inflammatory skin lesions: is sclerotic fibroma a distinct entity? J Cutan Pathol, 31, 3738.Google Scholar
Bhambri, A. and Del Rosso, J.Q. (2009). Solitary sclerotic fibroma. J Clin Aesthet Dermatol, 2, 36–8.Google Scholar
Chen, T.M., Purohit, S.K., and Wang, A.R. (2002). Pleomorphic sclerotic fibroma: a case report and literature review. Am J Dermatopathol, 24, 54–8.Google Scholar
Nascimento, A.F. (2013). Calcifying fibrous tumor. In WHO Classification of Tumors of Soft Tissue and Bone. 4th ed. Lyon: IARC, 50–1.Google Scholar
Bell, D.M., Dekmezian, R.H., Husain, S.A., et al. (2008). Oral calcifying fibrous pseudotumor: case analysis and review. Head Neck Pathol, 2, 343–7.Google Scholar
Azam, M., Husen, Y., and Pervez, S. (2009). Calcifying fibrous pseudotumor in assocation with hyaline vascular type Castleman's Disease. Indian J Pathol Microbiol, 52, 527–9.Google Scholar
Fletcher, C., Bridge, J., Hogendoorn, P., et al. (2013). WHO Classification of Tumors of Soft Tissue and Bone. 4th ed. Lyon: IARC, 50–1.Google Scholar
Fetsch, J.F. and Miettinen, M. (1998). Calcifying aponeurotic fibroma: a clinicopathologic study of 22 cases arising in uncommon sites. Hum Pathol, 29, 1504–10.Google Scholar
Hocar, O., Yacoubi, H., Akhdari, N., et al. (2011). Unusual presentation of a rare tumor of the dorsal surface of the foot. ISRN Dermatol, 2011.Google Scholar
Thway, K., Gibson, S., Ramsay, A., et al. (2008). Beta-catenin expression in pediatric fibroblastic and myofibroblastic lesions: a study of 100 cases. Pediatr Dev Pathol, 12, 292–6.Google Scholar
Fletcher, C., Bridge, J., Hogendoorn, P., et al. (2013). WHO Classification of Tumors of Soft Tissue and Bone. 4th ed. Lyon: IARC, 50–1.Google Scholar
Nishio, J. (2013). Updates on the cytogenetics and molecular cytogenetics of benign and intermediate soft tissue tumors (Review). Oncol Lett, 5, 1218.Google Scholar
Nagaraja, V., Coleman, H.G., and Morgan, G.J. (2013). Desmoplastic fibroblastoma presenting as a parotid tumor: a case report and review of the literature. Head Neck Pathol, 7, 285–90.Google Scholar
Failla, V., Wauters, O., Nikkels-Tassoudji, N., et al. (2009). Congenital infantile digital fibromatosis: a case report and review of the literature. Rare Tumors, 1, e47.Google Scholar
Grenier, N., Liang, C., Capaldi, L., et al. (2008). A range of histologic findings in infantile digital fibromatosis. Pediatr Dermatol, 25, 72–5.Google Scholar
Laskin, W.B., Miettinen, M., and Fetsch, J.F. (2009). Infantile digital fibroma/fibromatosis: a clinicopathologic and immunohistochemical study of 69 tumors from 57 patients with long-term follow-up. Am J Surg Pathol, 33, 113.Google Scholar
Fritchie, K., Carver, P., Sun, Y., et al. (2012). Solitary fibrous tumor: Is there a molecular relationship with cellular angiofibroma, spindle cell lipoma, and mammary-type myofibroblastoma? Am J Clin Pathol, 137, 963–70.Google Scholar
Chen, E. and Fletcher, C. (2010). Cellular angiofibroma with atypia or sarcomatous transformation: clinicopathologic analysis of 13 cases. Am J Surg Pathol, 34, 707–14.Google Scholar
Flucke, U., van Krieken, J., and Mentzel, T. (2011). Cellular angiofibroma: analysis of 25 cases emphasizing its relationship to spindle cell lipoma and mammary-type myofibroblastoma. Modern Pathology, 24, 82–9.Google Scholar
Fletcher, C., Bridge, J., Hogendoorn, P., et al. (2013). WHO Classification of Tumors of Soft Tissue and Bone. 4th ed. Lyon: IARC, 50–1.Google Scholar
Dei Tos, A.P., Seregard, S., Calonje, E., et al. (1995). Giant cell angiofibroma. A distinctive orbital tumor in adults. Am J Surg Pathol, 19, 1286–93.Google Scholar
Kucher, C. and McNiff, J.M. (2007). Epithelioid fibrous papule – a new variant. J Cutan Pathol, 34, 571–5.Google Scholar
Bansal, C., Stewart, D., Li, A., et al. (2005). Histologic variants of fibrous papule. J Cutan Pathol, 32, 424–8.Google Scholar
Kamino, H., Reddy, V., and Pui, J. (2012). Fibrous and fibrohistiocytic proliferations of skin and tendons. In: Dermatology . 3rd ed. Philadelphia: Elsevier, 1961–77.Google Scholar
Schaffer, J.V., Gohara, M.A., McNiff, J.M., et al. (2005). Multiple facial angiofibromas: a cutaneous manifestation of Birt-Hogg-Dubé syndrome. J Am Acai Dermatol, 53, S108–11.Google Scholar
Dei Tos, A.P., Seregard, S., Calonje, E., et al. (1995). Giant cell angiofibroma. A distinctive orbital tumor in adults. Am J Surg Pathol, 19, 1286–93.Google Scholar
Beer, T.W., Lam, M.H., and Heenan, P.J. (2009). Tumors of fibrous tissue involving the skin. Lever's Histopathology of the Skin. 10th ed. Philadelphia: Lipincott Williams & Wilkins, 989–90.Google Scholar
Choi, J.E., Jung, S.Y., Chun, J.S., et al. (2001). Giant acquired digital fibrokeratoma occurring on the left great toe. Ann Dermatol, 23, 64–6.Google Scholar
Johnson, R.B. (2011). Weedon's Skin Pathology Essentials. China: Churchill Livingstone.Google Scholar
McNiff, J.M., Subtil, A., Cowper, S.E., et al. (2005). Cellular digital fibromas: distinctive CD34-positive lesions that may mimic dermatofibrosarcoma protuberans. J Cutan Pathol, 32, 413–18.Google Scholar
Ashby-Richardson, H., Rogers, G., and Stadecker, M. (2011). Superficial acral fibromyxoma: an overview. Arch Pathol Lab Med, 135, 1064–6.Google Scholar
Tardío, J.C. (2009). CD34-reactive tumors of the skin. An updated review of an ever-growing list of lesions. J Cutan Pathol, 36, 1079–92.Google Scholar
Lewin, M.R., Montgomery, E.A., and Barrett, T.L. (2011). New or unusual dermatopathology tumors: a review. J Cutan Pathol, 38, 689–96.Google Scholar
Kamino, H., Reddy, V., and Pui, J. (2012). Fibrous and fibrohistiocytic proliferations of skin and tendons. In: Bolognia JL, Jorizzo JL and Schaffer JV, eds. Dermatology . 3rd ed. Philadelphia: Elsevier, 1961–77.Google Scholar
Al-Daraji, W.I. and Miettinen, M. (2008). Superficial acral fibromyxoma: a clinicopathologic analysis of 32 tumors including 4 in the heel. J Cutan Pathol, 35, 1020–6.Google Scholar
Fetsch, J.F., Laskin, W.B., and Miettinen, M. (2001). Superficial acral fibromyxoma: a clinicopathologic and immunohistochemical analysis of 37 cases of a distinctive soft tissue tumor with a predilection for the fingers and toes. Human Pathol, 32, 705–14.Google Scholar
Tardío, J.C. (2008). CD34-reactive tumors of the skin. An updated review of an ever-growing list of lesions. J Cutan Pathol, 36, 1079–92.Google Scholar
Coffin, C.M. and Alaggio, R. (2012). Fibroblastic and myofibroblastic tumors in children and adolescents. Pediatr Dev Pathol, 15, 127–80.Google Scholar
Erdag, G., Qureshi, H.S., Patterson, J.W., et al. (2007). Solitary fibrous tumors of the skin: a clinicopathologic study of 10 cases and review of the literature. J Cutan Pathol, 34, 844–50.Google Scholar
Wood, L., Fountaine, T. J., Rosamilia, L., et al. (2010). Cutaneous CD34+ spindle cell neoplasms: histopathologic features distinguish spindle cell lipoma, solitary fibrous tumor, and dermatofibrosarcoma protuberans. Am J Dermatopathol, 32, 764–8.Google Scholar
Clarke, L. E. (2012). Fibrous and fibrohistiocytic neoplasms: an update. Dermatol Clin, 30, 643–56.Google Scholar
Alves, J. V. P., Matos, D. M., Barreiros, H. F., et al. (2014). Variants of dermatofibroma – a histopathologic study. An Bras Dermatol, 89, 472–7.Google Scholar
Brenn, T. (2014). Pleomorphic dermal neoplasms: A review. Adv Anat Pathol, 21, 108–30.Google Scholar
Kamino, H., Reddy, V., and Pui, J. (2012). Fibrous and fibrohistiocytic proliferations of skin and tendons. In: Dermatology. 3rd ed. Philadelphia: Elsevier, 1962–4.Google Scholar
Luzar, B. and Calonje, E. (2010). Cutaneous fibrohistiocytic tumors – an update. Histopathology, 56, 148–65.Google Scholar
Sánchez Yus, E., Soria, L., de Eusebio, E., and Requena, L (2000). Lichenoid, erosive and ulcerated dermatofibromas. Three additional clinic-pathologic variants. J Cutan Pathol, 27, 112–17Google Scholar
Garrido-Ruiz, M. C., Carrillo, R., Enguita, A. B., et al. (2009). Signet-ring cell dermatofibroma. Am J Dermatopathol, 31, 84–7.Google Scholar
Kuo, T. T. and Chan, H. L. (1994). Ossifying dermatofibroma with osteoclast-like giant cells. Am J Dermatopathol, 16, 193–5.Google Scholar
Gonzalez-Vela, M. C., Val-Bernal, J. F., Martino, M., et al. (2005). Sclerotic fibroma-like dermatofibroma: an uncommon distinctive variant of dermatofibroma. Histol Histopathol, 20, 801–6.Google ScholarPubMed
Gleason, B. C. and Fletcher, C. D. (2008). Deep “benign” fibrous histiocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating occasional metastatic potential. Am J Surg Pathol, 32, 354–62.Google Scholar
Rodríguez-Jurado, R., Palacios, C., and Durán-McKinster, C. (2004). Medallion-like dermal dendrocyte hamartoma: a new clinically and histopathologically distinct lesion. J Am Acad Dermatol, 51, 359–63.Google Scholar
Kutzner, H., Mentzel, T., Palmedo, G., et al. (2010). Plaque-like CD34-positive dermal fibroma (“medallion-like dermal dendrocyte hamartoma”): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans. Am J Surg Pathol, 34, 190201.Google Scholar
Marque, M., Bessis, D., Pedeutour, F., et al. (2009). Medallion-like dermal dendrocyte hamartoma: the main diagnostic pitfall is congenital atrophic dermatofibrosarcoma. Br J Dermatol, 160, 190–3.Google Scholar
Restano, L., Fanoni, D., Colonna, C., et al. (2010). Medallion-like dermal dendrocyte hamartoma: a case misdiagnosed as neurofibroma. Pediatr Dermatol, 27, 638–42.Google Scholar
Alves, J., Matos, D., Barreiros, H., et al. (2014). Variants of dermatofibroma – a histopathologic study. An Bras Dermatol, 89, 472–7.Google Scholar
Luzar, B. and Calonje, E. (2010). Cutaneous fibrohistiocytic tumors – an update. Histopathology, 56, 148–65.Google Scholar
Kamino, H., Reddy, V.B., and Pui, J. (2012). Fibrous and fibrohistiocytic proliferations of the skin and tendons. In Dermatology. Philadelphia: Elsevier, 1961–77.Google Scholar
Kamino, H. and Jacobson, M. (1990). Dermatofibroma extending into the subcutaneous tissue. Differential diagnosis from dermatofibrosarcoma protuberans. Am J Surg Pathol, 14, 1156–64.Google Scholar
Calderaro, J., Rethers, L., and Ortonne, N. (2010). Multinucleated cells angiohistiocytoma: a reactive lesion? Am J Dermatopathol, 32, 415–17.Google Scholar
Cesinaro, A. M., Roncati, L., and Maiorana, A. (2010). Estrogen receptor alpha overexpression in multinucleate cell angiohistiocytoma: new insights into the pathogenesis of a reactive process. Am J Dermatopathol, 32, 655–9.Google Scholar
Jones, E. W., Cerio, R., and Smith, N. P. (1990). Multinucleate cell angiohistiocytoma: an acquired vascular anomaly to be distinguished from Kaposi's sarcoma. Br J Dermatol, 122, 651–63.Google Scholar
Jaconelli, L., Kanitakis, J., Ktiouet, S., et al. (2009). Multinucleate cell angiohistiocytoma: report of three new cases and literature review. Dermatol Online J, 15.Google Scholar
Nishio, J. (2013). Updates on the cytogenetics and molecular cytogenetics of benign and intermediate soft tissue tumors (Review). Oncol Lett, 5, 1218.Google Scholar
Holst, V. A. and Elenitsas, R. (2001). Primary giant cell tumor of soft tissue. J Cutan Pathol, 28, 492–5.Google Scholar
Zelger, B. (2002). Connective tissue tumors. Recent Results Cancer Res, 160, 343–50.Google Scholar
Fletcher, C., Bridge, J., Hogendoorn, P., et al. (2013). WHO Classification of Tumors of Soft Tissue and Bone. 4th ed. Lyon: IARC.Google Scholar
Bohman, S. L., Goldblum, J. R., Rubin, B. P., et al. (2014). Angiomatoid fibrous histiocytoma: an expansion of the clinical and histologic spectrum. Pathology, 46, 199204.CrossRefGoogle Scholar
Thway, K. (2008). Angiomatoid fibrous histiocytoma: a review with recent genetic findings. Arch Pathol Lab Med, 132, 273.Google Scholar
Allen, P. W. (1977). The fibromatoses: A clinicopathologic classification based on 140 cases Part 1. Am J Surg Pathol, 1, 255–70.Google Scholar
Fletcher, C., Bridge, J., Hogendoorn, P., et al. (2013). WHO Classification of Tumors of Soft Tissue and Bone. 4th ed. Lyon: IARC, 46–7.Google Scholar
Zelger, B. (2002). Connective tissue tumors. Recent Results Cancer Res, 160, 343–50.Google Scholar
Fisher, C. and Thway, K. (2014). Aggressive fibromatosis. Pathology, 46, 135–40.Google Scholar
Montgomery, E., Lee, J. H., Abraham, S. C., et al. (2001). Superficial fibromatoses are genetically distinct from deep fibromatoses. Mod Pathol, 14, 695701.Google Scholar
Fetsch, J. F., Laskin, W. B., and Miettinen, M. (2005). Palmar-plantar fibromatosis in children and preadolescents: a clinicopathologic study of 56 cases with newly recognized demographics and extended follow-up information. Am J Surg Pathol, 29, 1095–105.Google Scholar
Coffin, C. M. and Alaggio, R. (2012). Fibroblastic and myofibroblastic tumors in children and adolescents. Pediatr Dev Pathol, 15, 127–80.CrossRefGoogle ScholarPubMed
Salehinejad, J., Pazouki, M., and Gerayeli, M. A. (2013). Malignant inflammatory myofibroblastic tumor of the maxillary sinus. J Oral Maxillofac Pathol, 17, 306–10.Google Scholar
Owusu-Brackett, N., Johnson, R., Schindel, D. T., et al. (2013). A novel ALK rearrangement in an inflammatory myofibroblastic tumor in a neonate. Cancer Genet, 206, 353–6.Google Scholar
Enzinger, F. M. and Zhang, R. (1988). Plexiform fibrohistiocytic tumor presenting in children and young adults: an analysis of 65 cases. Am J Surg Pathol, 12, 818–26.Google Scholar
Moosavi, C., Jha, P., and Fanburg-Smith, J. C. (2007). An update on plexiform fibrohistiocytic tumor and addition of 66 new cases from the Armed Forces Institute of Pathology, in honor of Franz M. Enzinger, MD. Ann Diag Pathol, 11, 313–19.Google Scholar
Luzar, B. and Calonje, E. (2010). Cutaneous fibrohistiocytic tumors: an update. Histopathology, 56, 148–65.Google Scholar
Jacobson-Dunlop, E., White, C. R. Jr, and Mansoor, A. (2011). Features of plexiform fibrohistiocytic tumor in skin punch biopsies: a retrospective study of 6 cases. Am J Dermatopathol, 33, 551–6.Google Scholar
Jaffer, S., Ambrosini-Spaltro, A., Mancini, A. M., et al. (2009). Neurothekeoma and plexiform fibrohistiocytic tumor: mere histologic resemblance or histogenetic relationship?. Am J Surg Pathol, 33, 905–13.Google Scholar
Fretzin, D. F. and Helwig, E. B. (1973). Atypical fibroxanthoma of the skin. A clinicopathologic study of 140 cases. Cancer, 31, 1541–52.3.0.CO;2-6>CrossRefGoogle ScholarPubMed
Mirza, B. and Weedon, D. (2005). Atypical fibroxanthoma: a clinicopathologic study of 89 cases. Australas J Dermatol, 46, 235–8.Google Scholar
Clarke, L. E. (2012). Fibrous and fibrohistiocytic neoplasms: an update. Dermatol Clin, 30, 643–56.Google Scholar
Luzar, B. and Calonje, E. (2010). Cutaneous fibrohistiocytic tumors: an update. Histopathology, 56, 148–65.Google Scholar
Miller, K., Goodlad, J. R., & Brenn, T. (2012). Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma. Am J Surg Pathol, 36, 1317–26.Google Scholar
Brenn, T. (2014). Pleomorphic dermal neoplasms: A review. Adv Anat Pathol, 21, 108–30.Google Scholar
Thum, C., Husain, E. A., Mulholland, K., et al. (2013). Atypical fibroxanthoma with pseudoangiomatous features: a histologic and immunohistochemical mimic of cutaneous angiosarcoma. Ann Diag Pathol, 17, 502–7.Google Scholar
Taylor, H. B. and Helwig, E. B. (1962). Dermatofibrosarcoma protuberans. A study of 115 cases. Cancer, 15, 717–25.Google Scholar
Fletcher, C., Bridge, J., Hogendoorn, P., et al. (2013). WHO Classification of Tumors of Soft Tissue and Bone. 4th edn. Lyon: IARC, 46–7.Google Scholar
Tardío, J. C. (2009). CD34‐reactive tumors of the skin. An updated review of an ever‐growing list of lesions. J Cutan Pathol, 36, 89102.Google Scholar
Stivala, A., Lombardo, G. A., Pompili, G., et al. (2012). Dermatofibrosarcoma protuberans: Our experience of 59 cases. Oncol Lett, 4, 1047–55.Google Scholar
Kamino, H. and Jacobson, M. (1990). Dermatofibrome extending into the subcutaneous tissue: differential diagnosis from dermatofibrosarcoma protuberans. Am J Surg Pathol, 14, 1156–64.Google Scholar
Rutkowski, P., Wozniak, A., and Switaj, T. (2011). Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans. Sarcoma. doi: 10.1155/2011/959132 [Epub Mar 30 2011].Google Scholar
Kutzner, H. (1993). Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue. J Am Acad Dermatol, 28, 613–17.Google Scholar
Kamino, H., Burchette, J., and Garcia, J. A. (1992). Immunostaining for CD34 in plaque and nodular areas of dermatofibrosarcoma protuberans. J Cutan Pathol, 19, 8.Google Scholar
Jha, P., Moosavi, C., and Fanburg-Smith, J. C. (2007). Giant cell fibroblastoma: an update and addition of 86 new cases from the Armed Forces Institute of Pathology, in honor of Dr. Franz M. Enzinger. Ann Diag Pathol, 11, 81–8.Google Scholar
Harvell, J. D., Kilpatrick, S. E., and White, W. L. (1998). Histogenetic relations between giant cell fibroblastoma and dermatofibrosarcoma protuberans: CD34 staining showing the spectrum and a simulator. Am J Dermatopathol, 20, 339–45.Google Scholar
Shmookler, B. M., Enzinger, F. M., and Weiss, S. W. (1989). Giant cell fibroblastoma. A juvenile form of dermatofibrosarcoma protuberans. Cancer, 64, 2154–61.Google Scholar
Qiao, J., Patel, K. U., López-Terrada, D., et al. (2012). Atrophic dermatofibrosarcoma protuberans: report of a case demonstrated by detecting COL1A1-PDGFB rearrangement. Diagn Pathol, 7, 166.Google Scholar
Kutzner, H., Mentzel, T., Palmedo, G., et al. (2010). Plaque-like CD34-positive dermal fibroma (“medallion-like dermal dendrocyte hamartoma”): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans. Am J Surg Pathol, 34, 190201.Google Scholar
Evans, H. L. (1993). Low-grade fibromyxoid sarcoma: a report of 12 cases. Am J Surg Pathol, 17, 595600.Google Scholar
Evans, H. L. (2011). Low-grade fibromyxoid sarcoma: a clinicopathologic study of 33 cases with long-term follow-up. Am J Surg Pathol, 35, 1450–62.Google Scholar
Abe, Y., Hashimoto, I., and Nakanishi, H. (2012). Recurring facial low-grade fibromyxoid sarcoma in an elderly patient: A case report. J Med Invest, 59, 266–9.Google Scholar
Coffin, C. M. and Alaggio, R. (2012). Fibroblastic and myofibroblastic tumors in children and adolescents. Pediatr Dev Pathol, 15, 127–80.Google Scholar
Fletcher, C., Bridge, J., Hogendoorn, P., et al. (2013). WHO Classification of Tumors of Soft Tissue and Bone. 4th ed. Lyon: IARC.Google Scholar
Lane, K. L., Shannon, R. J., and Weiss, S. W. (1997). Hyalinizing spindle cell tumor with giant rosettes: a distinctive tumor closely resembling low-grade fibromyxoid sarcoma. Am J Surg Pathol, 21, 1481–8.Google Scholar
Cai, C., Dehner, L. P., and El-Mofty, S. K. (2013). In myofibroblastic sarcomas of the head and neck, mitotic activity and necrosis define grade: a case study and literature review. Virchows Archiv, 463, 827–36.Google Scholar
Qiu, X., Montgomery, E., and Sun, B. (2008). Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts. Hum Pathol, 39, 846–56.Google Scholar
Covello, R., Licci, S., Pichi, B., et al. (2011). Low-grade myofibroblastic sarcoma of the larynx. Int J Surg Pathol, 19, 822–6.Google Scholar
Coffin, C. M. and Alaggio, R. (2012). Fibroblastic and myofibroblastic tumors in children and adolescents. Pediatr Dev Pathol, 15, 127–80.Google Scholar
Nishio, J. (2013). Updates on the cytogenetics and molecular cytogenetics of benign and intermediate soft tissue tumors (Review). Oncol Letts, 5, 1218.Google Scholar
Tardío, J. C. (2009). CD34‐reactive tumors of the skin. An updated review of an ever‐growing list of lesions. J Cutan Pathol, 36, 89102.Google Scholar
Zelger, B. (2002). Connective tissue tumors. Recent Results Cancer Res, 160, 343–50.Google Scholar
Coffin, C. M. and Alaggio, R. (2012). Fibroblastic and myofibroblastic tumors in children and adolescents. Pediatr Dev Pathol, 15(sp1), 127–80.Google Scholar
Fletcher, C., Bridge, J., Hogendoorn, P., et al. (2013). WHO Classification of Tumors of Soft Tissue and Bone. 4th ed. Lyon: IARC.Google Scholar
Fisher, C. (2004). Myofibroblastic malignancies. Adv Anat Pathol, 11, 190201.Google Scholar
Folpe, A. L. (2014). Fibrosarcoma: a review and update. Histopathology, 64, 1225.Google Scholar
Coffin, C. M. and Alaggio, R. (2012). Fibroblastic and myofibroblastic tumors in children and adolescents. Pediatr Dev Pathol, 15(sp1), 127–80.Google Scholar
Fletcher, C., Bridge, J., Hogendoorn, P., et al. (2013). WHO Classification of Tumors of Soft Tissue and Bone. 4th ed. Lyon: IARC.Google Scholar
Folpe, A. L. (2014). Fibrosarcoma: a review and update. Histopathology, 64, 1225.Google Scholar
Clarke, L. E. (2012). Fibrous and fibrohistiocytic neoplasms: an update. Dermatol Clin, 30, 643–56.Google Scholar
Coffin, C. M. and Alaggio, R. (2012). Fibroblastic and myofibroblastic tumors in children and adolescents. Pediatr Dev Pathol, 15(sp1), 127–80.Google Scholar
Brenn, T (2014). Pleomorphic dermal neoplasms: a review. Adv Anat Pathol, Mar, 21:108130.Google Scholar
Fletcher, C., Bridge, J., Hogendoorn, P., et al. (2013). WHO Classification of Tumors of Soft Tissue and Bone. 4th ed. Lyon: IARC.Google Scholar
Clarke, L. E., Zhang, P. J., Crawford, G. H., et al. (2008). Myxofibrosarcoma in the skin. J Cutan Pathol, 35, 935–40.Google Scholar
Erlandson, R. A. and Antonescu, C. R. (2004). The rise and fall of malignant fibrous histiocytoma. Ultrastruct Pathol, 28, 283–9.Google Scholar
Al-Agha, O. M. and Igbokwe, A. A. (2008). Malignant fibrous histiocytoma: between the past and the present. Arch Pathol Lab Med, 132, 1030–5.Google Scholar
Tong, L., Wang, Y., Zhou, Y., et al. (2014). Surgical management of giant secondary malignant fibrous histiocytoma following radiotherapy for nasopharyngeal carcinoma: A case report and literature review. Oncol Lett, 8, 72–6.Google Scholar
Chase, D. R. and Enzinger, F. M. (1985). Epithelioid sarcoma: Diagnosis, prognostic indicators, and treatment. Am J Surg Pathol, 9, 241–63.Google Scholar
Evans, H. L. and Baer, S. C. (1993). Epithelioid sarcoma: a clinicopathologic and prognostic study of 26 cases. Semin Diagn Pathol, 10, 286–91.Google Scholar
Callister, M. D., Ballo, M. T., Pisters, P. W., et al. (2001). Epithelioid sarcoma: results of conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys, 51, 384–91.Google Scholar
Tardío, J. C. (2009). CD34‐reactive tumors of the skin. An updated review of an ever‐growing list of lesions. J Cutan Pathol, 36, 89102.Google Scholar
Folpe, A. L. (2014). Selected topics in the pathology of epithelioid soft tissue tumors. Mod Pathol, 27, S6479.Google Scholar
Fletcher, C., Bridge, J., Hogendoorn, P., et al. (2013). WHO Classification of Tumors of Soft Tissue and Bone. 4th edn. Lyon: IARC.Google Scholar
Kang, Y., Pekmezci, M., Folpe, A. L., et al. (2014). Diagnostic utility of SOX10 to distinguish malignant peripheral nerve sheath tumor from synovial sarcoma, including intraneural synovial sarcoma. Mod Pathol, 27, 5561.Google Scholar
Thway, K. and Fisher, C. (2014). Synovial sarcoma: defining features and diagnostic evolution. Ann Diag Pathol, 18, 369–80.Google Scholar
Kerouanton, A., Jimenez, I., Cellier, C., et al. (2014). Synovial sarcoma in children and adolescents. J Pediatr Hematol Oncol, 36, 257–62.Google Scholar
Saito, T. (2013). The SYT-SSX fusion protein and histologic epithelial differentiation in synovial sarcoma: relationship with extracellular matrix remodeling. Int J Clin Exp Pathol, 6, 2272.Google Scholar
Miettinen, M. (2014). Immunohistochemistry of soft tissue tumors – review with emphasis on 10 markers. Histopathology, 64, 101–18.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×